The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
insulin does two a couple other beneficial things is that insulin actually lowers glucagon levels and glucagon levels are highly associated with type 2 diabetes so what they talk about here is patients with type 2 diabetes suffer from fasting and postprandial hyperglucagonemia which stimulates hepatic glucose production and thus contributes to hypoglycemia
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.